Life Sciences — In Focus Episode 17 with Julieta Pacheco
Life Sciences - In Focus
Let's TalkLife Sciences - In Focus provides an exciting platform to explore the constantly evolving world of life sciences through insightful conversations with industry leaders.
Catch up on the latest panel discussions and podcast episodes below. Once a month, hosts Karen Tkaczyk and Maria Mateos present fresh, compelling conversations with great minds from the life sciences industry and beyond!
Catch up on the latest panel discussions and podcast episodes below. Once a month, hosts Karen Tkaczyk and Maria Mateos present fresh, compelling conversations with great minds from the life sciences industry and beyond!
Latest Release
In Focus: Panel Discussion Episode 7
Laboratory Developed Tests: What Now, Where Next?
This Life Sciences – In Focus Panel brought together leading regulatory experts to discuss a hot topic in the diagnostics industry: Laboratory Developed Tests (LDTs) and their tumultuous regulatory journey. Hosted by Karen Tkaczyk, Director of Sales at Vistatec Life Sciences, the panel featured Cortez McBerry (Regulatory Consulting Director at NDA Partners), Sean McCarthy (Senior Regulatory Manager at Enhanced Compliance, Inc.), and Tristin Wolff Cope (Director of Regulatory Compliance at Biodesix). Their insights not only unraveled the complexities of LDT oversight but also emphasized the pressing need to bridge gaps in regulatory frameworks.
In Focus Podcast
In Focus Panel Discussion
Ep 6: Amplifying Patient Voices in Clinical Research: Strategies for Engaging Non-English Speakers
Clinical trials serve as the backbone of medical innovation, yet a significant portion of the global population remains underrepresented due to language barriers. In this episode, moderator Karen Tkaczyk led a compelling discussion on strategies for engaging non-English speakers in clinical research. Featuring Julie Blasingim (CEO, Univo IRB), Harsha Rajasimha (CEO, Jeeva Clinical Trials), and Lya Rebelo (Commercial Enablement Manager, Citeline), the conversation tackled regulatory challenges, ethical considerations, and the role of technology in fostering inclusivity.
Watch NowEp 5: Breaking Barriers: Enhancing Diversity and Inclusion in Clinical Research
Clinical research holds the key to groundbreaking treatments and improved health outcomes. But for far too long, it has struggled to represent the people it aims to serve, particularly underserved communities. A recent Life Sciences – In Focus panel discussion titled "Breaking Barriers: Enhancing Diversity and Inclusion in Clinical Research" shed light on these systemic issues while offering innovative, practical solutions to create more equitable and inclusive trials.
Watch NowEp 4: FDA Diversity Action Plans: Deciphering the Guidance and its Consequences
The US Food and Drug Administration has released long-awaited updated guidance on Diversity Action Plans. This guidance is stronger and very specific in places. In this panel discussion, Vistatec invites industry-leading experts Aman Khera, Joan A. Chambers, and Lya Rebelo to explore how both large and small sponsors are responding to these changes. Through real-world examples, they discuss the implications of these plans on site burden, patient experience, and how clinical operations and regulatory affairs teams are applying this US-focused guidance in global trials. Click the video to watch the recording of this essential conversation.
Watch NowEp 3: Navigating the Regulatory Landscape - Latin America Edition
Through case studies and real-world examples, learn from success stories and lessons gained from navigating the complex regulatory environment in Latin America. Vistatec invited industry-leading experts to share the latest regulatory updates and trends and understand their implications for clinical research and development. Click the video to watch the recording of the panel discussion.
Watch NowEp 2: Real-World Evidence: Global Regulatory Landscape and Innovation
Real-world evidence (RWE) has been a hot topic in recent years, not only in the research and life sciences industry but also in public health. Given the challenges surrounding its ethical use and regulation, the increasing importance of AI and the sheer volume of data available, the discussion is sure to continue. Vistatec invited industry-leading experts to share their insights, thoughts, and predictions on the role of RWE going forward. Click the video to watch the recording of the panel discussion, or read the key learnings here.
Watch NowEp 1: Leveraging Data and Trends for 2024
In the first installment of Vistatec's Life Sciences - In Focus series, Amanda Murphy, Senior Director of Data Intelligence and Solutions at GlobalData, presented the biopharmaceutical industry's outlook for 2024. The event yielded valuable insights into the trends and themes predicted for the upcoming year, focusing on the clinical trials landscape, including decentralized clinical trials and diversity. Click the video to watch the recording, or read the key learnings from the event here.
Watch Now